News | August 04, 2021
Dr Reddy’s relaunch Naproxen Sodium Tablets in the US
It is part of the company’s pain/analgesics portfolio of OTC products
It is part of the company’s pain/analgesics portfolio of OTC products
Vikas Lifecare has already paid Rs. 25 million to the Advik bankers till date and the remaining amount shall also be paid within July 2021, making Advik a debt free company
The five pharma companies have entered into a collaboration agreement, wherein the parties will jointly sponsor, supervise and monitor the clinical trial in India
Targeted production of the dual vector Sputnik V for the first 12 months is 50 million doses from the date of start of commercial production
Market penetration of Sputnik V will depend on competitive pricing, government orders and the ability to meet soaring demand through timely supply
The government has taken all the effective measures to make healthcare affordable
Subscribe To Our Newsletter & Stay Updated
